ALEXIS EUART: Open Payments
NPI 1831761204 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 48 payments from 13 companies in 2025. Trend: 2023 $1,848 · 2024 $1,582 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $247 |
| Novartis Pharmaceuticals Corporation | 8 | $165 |
| Medtronic, Inc. | 9 | $143 |
| HEARTFLOW, INC. | 1 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| PFIZER INC. | 3 | $49 |
| Lilly USA, LLC | 2 | $39 |
| BridgeBio Pharma, Inc. | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $20 |
Products named: VERQUVO, LEQVIO, FFRct, JARDIANCE, CAMZYOS, LINQ II, MICRA, Attruby.
Industry payments across TX — which companies pay providers there.
